Ontozry 100 mg is a prescription antiepileptic medicine in the form of film-coated tablets containing cenobamate. It is used as an add-on treatment in adults whose focal-onset (partial) seizures are not controlled by at least two previous antiepileptic treatments. This is a French-market pack of 28 tablets; the marketing-authorisation holder is Angelini Pharma S.p.A. (Italy). In the European Union the medicine is subject to additional monitoring.
According to the EU summary of product characteristics, Ontozry is indicated in adults with epilepsy that has not been controlled by at least two previous treatments, for the adjunctive (add-on) treatment of focal-onset seizures with or without secondary generalisation. It is always taken together with other antiepileptic medicines, not instead of them.
Cenobamate is taken once a day at the same time each day, with or without food; the tablet is swallowed whole with a glass of water. Treatment must be started at 12.5 mg once daily and increased slowly — the titration schedule has to be followed strictly because of the risk of serious adverse reactions:
The tablets have no break line and cannot be split accurately. They may be taken whole or crushed; a crushed tablet can be mixed with water and given by mouth or through a nasogastric tube.
The most frequently reported reactions are somnolence, dizziness, fatigue and headache. In clinical studies the most common reasons for stopping treatment were ataxia, dizziness, somnolence, nystagmus, vertigo and double vision — these reactions are dose-related, which is why the titration schedule must be respected.
Seek medical help immediately if fever or a skin rash appears, especially together with swollen glands or feeling generally unwell — these can be the first signs of a serious hypersensitivity reaction.
Shelf life 5 years. This medicine does not require any special storage conditions. Keep out of the sight and reach of children. Do not use after the expiry date printed on the pack.
The pack photo is shown for identification purposes; packaging design and leaflet language may vary between markets. This text summarises the official EU product information and is not a substitute for the advice of your doctor or pharmacist. Ontozry is a prescription medicine and must be used only under medical supervision.
📦 Ask about availability and delivery to your country on WhatsApp


